Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIM: Roflumilast in Asthma Management
NCT03532490Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2018
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Roflumilast with Placebo (2 arms). Primary endpoint: Asthma Control Test at 24 weeks. Started Aug 2018; status: completed.
02
Drugs
roflumilast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03532490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03532490.